z-logo
open-access-imgOpen Access
<p>Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications</p>
Author(s) -
Elsa Patricia Rondon,
Houda Abir Benabdoun,
Francis Vallières,
Maicon Segalla Petrônio,
Márcio José Tiera,
Mohamed Benderdour,
Julio Fernandes
Publication year - 2020
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s252397
Subject(s) - hemolysis , peripheral blood mononuclear cell , polyethylene glycol , chemistry , chitosan , peg ratio , pharmacology , viability assay , in vitro , microbiology and biotechnology , biochemistry , immunology , medicine , biology , finance , economics
Diethylaminoethyl-chitosan (DEAE-CH) is a derivative with excellent potential as a delivery vector for gene therapy applications. The aim of this study is to evaluate its toxicological profile for potential future clinical applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here